CellSave Revenue and Competitors

Phoenix, AZ USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • CellSave's estimated annual revenue is currently $930k per year.(i)
  • CellSave's estimated revenue per employee is $155,000

Employee Data

  • CellSave has 6 Employees.(i)
  • CellSave grew their employee count by 20% last year.

CellSave's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.8M50%N/AN/A
#2
$0.9M60%N/AN/A
#3
$0.8M5-29%N/AN/A
#4
$5.3M340%N/AN/A
#5
$2.5M16-20%N/AN/A
#6
$1.1M70%N/AN/A
#7
$0.9M60%N/AN/A
#8
$2.2M2921%$58.2MN/A
#9
$171.9M1109-3%N/AN/A
#10
$0.9M60%N/AN/A
Add Company

What Is CellSave?

CellSave offers families across the globe the most advanced and comprehensive stem cell banking services in the world. Over the past 20 years, we have successfully collected and preserved stem cells from over 80 countries across six continents, always applying the most advanced technologies and highest industry standards. Our state-of-the-art stem cell laboratories are featuring advanced stem cell processing, testing and storage facilities worldwide. In the rapidly evolving field of stem cell therapies, CellSave is always on the lookout for the newest technologies and practices to better serve our clients needs. Our team of experienced medical experts are respected members of the international stem cell community and ensure that our laboratories stay on the forefront of innovation in the field. We pride ourselves in offering the highest standards and being a global leader for quality in our industry. Every sample receives individual care and high-quality processing from certified medical technologists, and a home in the most advanced state-of-the-art laboratory.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$930k

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M60%N/A
#2
$0.9M60%N/A
#3
$0.4M60%N/A
#4
$0.4M60%N/A
#5
$0.4M60%N/A